Insider trading · Q3 2026 · CIK 1658247

Crinetics Pharmaceuticals, Inc. (CRNX) insider trading.

Name: Crinetics Pharmaceuticals, Inc. insider transactions, Q3 2026
Creator: U.S. Securities and Exchange Commission

In Q3 2026, insiders at Crinetics Pharmaceuticals, Inc. reported 38 non-derivative transactions on 14 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $120K.

Transactions: 38
Purchases (P): 0
Sales (S): 1
Net shares, P minus S: -3,000
Insiders: 11
Last filed: 2026-09-01

Insiders

Insider	Relationship	Transactions	Sales
Struthers Richard Scott	Director, Officer · President & CEO	16	0
Schilke Tobin	Officer · Chief Financial & Infra. Ofcr.	3	0
Vivaldi Coelho Rogerio	Director	3	1
Betz Stephen F.	Officer · Chief Scientific Officer	2	0
Kalofonos Isabel	Officer · Chief Commercial Officer	2	0
Bedrosian Camille L	Director	2	0
Deardorf Caren	Director	2	0
Fust Matthew K	Director	2	0
Nichols Weston	Director	2	0
Okey Stephanie	Director	2	0
Wierenga Wendell	Director	2	0

Transactions

38 non-derivative rows, newest transaction first. Shares and prices as filed.
Date	Insider	Code	Shares	Price	Owned after	Filing
2026-09-01	Struthers Richard Scott	D (D)	100,000	$85	0	Form 4
2026-09-01	Struthers Richard Scott	D (D)	111,100	$85	0	Form 4
2026-09-01	Struthers Richard Scott	D (D)	111,100	$85	0	Form 4
2026-09-01	Struthers Richard Scott	D (D)	111,100	$85	0	Form 4
2026-09-01	Struthers Richard Scott	D (D)	111,100	$85	0	Form 4
2026-09-01	Struthers Richard Scott	D (D)	80,000	$85	0	Form 4
2026-09-01	Struthers Richard Scott	D (D)	176,663	$85	0	Form 4
2026-09-01	Struthers Richard Scott	D (D)	110,000	$85	0	Form 4
2026-09-01	Struthers Richard Scott	D (D)	106,000	$85	0	Form 4
2026-09-01	Struthers Richard Scott	D (D)	136,805	$85	0	Form 4
2026-09-01	Struthers Richard Scott	D (D)	248,043	$85	176,663	Form 4
2026-09-01	Struthers Richard Scott	D (D)	1,000	$85	0	Form 4
2026-09-01	Schilke Tobin	D (D)	71,471	$85	0	Form 4
2026-09-01	Schilke Tobin	D (D)	7,956	$85	71,471	Form 4
2026-09-01	Betz Stephen F.	D (D)	79,650	$85	0	Form 4
2026-09-01	Betz Stephen F.	D (D)	58,286	$85	79,650	Form 4
2026-09-01	Kalofonos Isabel	D (D)	34,000	$85	0	Form 4
2026-09-01	Kalofonos Isabel	D (D)	1,669	$85	34,000	Form 4
2026-09-01	Bedrosian Camille L	D (D)	16,300	$85	5,925	Form 4
2026-09-01	Bedrosian Camille L	D (D)	5,925	$85	0	Form 4
2026-09-01	Deardorf Caren	D (D)	5,925	$85	0	Form 4
2026-09-01	Deardorf Caren	D (D)	16,300	$85	5,925	Form 4
2026-09-01	Fust Matthew K	D (D)	22,836	$85	5,925	Form 4
2026-09-01	Fust Matthew K	D (D)	5,925	$85	0	Form 4
2026-09-01	Nichols Weston	D (D)	5,925	$85	0	Form 4
2026-09-01	Nichols Weston	D (D)	16,300	$85	5,925	Form 4
2026-09-01	Okey Stephanie	D (D)	6,400	$85	5,925	Form 4
2026-09-01	Okey Stephanie	D (D)	5,925	$85	0	Form 4
2026-09-01	Vivaldi Coelho Rogerio	D (D)	13,300	$85	5,925	Form 4
2026-09-01	Vivaldi Coelho Rogerio	D (D)	5,925	$85	0	Form 4
2026-09-01	Wierenga Wendell	D (D)	116,146	$85	5,925	Form 4
2026-09-01	Wierenga Wendell	D (D)	5,925	$85	0	Form 4
2026-08-20	Schilke Tobin	A (A)	471	$0	79,427	Form 4
2026-08-07	Struthers Richard Scott	M (A)	6,542	$15.29	419,711	Form 4
2026-08-07	Struthers Richard Scott	M (A)	4,995	$20.02	424,706	Form 4
2026-08-07	Struthers Richard Scott	M (A)	4,422	$22.61	413,169	Form 4
2026-08-07	Struthers Richard Scott	M (A)	3,969	$25.19	408,747	Form 4
2026-07-02	Vivaldi Coelho Rogerio	S (D)	3,000	$40	19,225	Form 4

Transaction codes in this quarter

D: 32 M: 4 A: 1 S: 1

Get CRNX insider transactions through the API

Request with your API key

curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1658247&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · Crinetics Pharmaceuticals, Inc. on SEC.gov

Questions

Are insiders buying or selling Crinetics Pharmaceuticals, Inc. (CRNX)?

In Q3 2026, insiders at Crinetics Pharmaceuticals, Inc. reported 38 non-derivative transactions on 14 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $120K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Crinetics Pharmaceuticals, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/crnx.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.